Zobrazeno 1 - 10
of 640
pro vyhledávání: '"Myeong Chan, Cho"'
Autor:
Sangshin Park, Min Kim, Dae In Lee, Ju-Hee Lee, Sangmin Kim, Sang Yeub Lee, Jang-Whan Bae, Kyung-Kuk Hwang, Dong-Woon Kim, Myeong-Chan Cho, Dae-Hwan Bae
Publikováno v:
Acute and Critical Care, Vol 39, Iss 1, Pp 194-198 (2024)
The main mechanism of Takotsubo cardiomyopathy (TCM) is catecholamine-induced acute myocardial stunning. Pheochromocytoma, a catecholamine-secreting tumor, can cause several cardiovascular complications, including hypertensive crisis, myocardial infa
Externí odkaz:
https://doaj.org/article/b3f28b093d51415ab4a8112e8e04d891
Autor:
Seung Hun Lee, Tae-Min Rhee, Doosup Shin, David Hong, Ki Hong Choi, Hyun Kuk Kim, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Joo-Yong Hahn, Seung-Hyuck Choi, Shung Chull Chae, Myeong-Chan Cho, Chong Jin Kim, Ju Han Kim, Hyo-Soo Kim, Hyeon-Cheol Gwon, Myung Ho Jeong, Joo Myung Lee, The KAMIR-NIH Investigators
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Prognostic effect of discontinuing renin–angiotensin–aldosterone-system-inhibitor (RAASi) for patients with heart failure (HF) after acute myocardial infarction (AMI) whose left ventricular (LV) systolic function was restored during foll
Externí odkaz:
https://doaj.org/article/5997da18d9e5420fb1af18d092a24a65
Autor:
Kyeong-Hyeon Chun, Jaewon Oh, Chan Joo Lee, Jin Joo Park, Sang Eun Lee, Min-Seok Kim, Hyun-Jai Cho, Jin-Oh Choi, Hae-Young Lee, Kyung-Kuk Hwang, Kye Hun Kim, Byung-Su Yoo, Dong-Ju Choi, Sang Hong Baek, Eun-Seok Jeon, Jae-Joong Kim, Myeong-Chan Cho, Shung Chull Chae, Byung-Hee Oh, Seok-Min Kang
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background High glycemic variability (GV) is a poor prognostic marker in cardiovascular diseases. We aimed to investigate the association of GV with all-cause mortality in patients with acute heart failure (HF). Methods The Korean Acute Hear
Externí odkaz:
https://doaj.org/article/edd0ab38cb0446c79e00b8c03f25e66b
Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction
Autor:
Gyu Chul Oh, Seokyung An, Hae‐Young Lee, Hyun‐Jai Cho, Eun‐Seok Jeon, Sang Eun Lee, Jae‐Joong Kim, Seok‐Min Kang, Kyung‐Kuk Hwang, Myeong‐Chan Cho, Shung Chull Chae, Dong‐Ju Choi, Byung‐Su Yoo, Kye Hun Kim, Sue K. Park, Sang Hong Baek
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 3232-3240 (2022)
Abstract Aims Increased blood pressure (BP) and decreased heart rate (HR) are signs of stabilization in patients admitted for acute HF. Changes in BP and HR during admission and their correlation with outcomes were assessed in hospitalized patients w
Externí odkaz:
https://doaj.org/article/ffd8945107f94a7ca72ad7a8e03d85c2
Autor:
Dong-Hwa Lee, Ju-Hee Lee, So Young Kim, Hae-Young Lee, Jung-Yeon Choi, Youjin Hong, Sue K. Park, Dong Ryeol Ryu, Dong Heon Yang, Seok-Jae Hwang, Jung Hyun Choi, Kye Hun Kim, Sun Hwa Lee, Seung Jae Joo, Jae-Hyeong Park, Sang-Hyun Kim, Hack-Lyong Kim, Kwang-il Kim, Myeong-Chan Cho
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 5, Pp 1070-1081 (2022)
Background/Aims The optimal systolic blood pressure (SBP) goal for elderly patients with hypertension, especially to reduce cardiovascular disease (CVD) incidence and improve outcome, is unclear. This study aimed to evaluate the beneficial effects of
Externí odkaz:
https://doaj.org/article/96e00de932d94679ae6fe7e85c3bba72
Autor:
Dae-Hwan Bae, Sangshin Park, Min Kim, Sangmin Kim, Woong Gil Choi, Jang-Whan Bae, Kyung-Kuk Hwang, Dong-Woon Kim, Myeong-Chan Cho, Ju-Hee Lee
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundPrimary cardiac tumors are rare, and malignant primary cardiac tumors are even rarer. Cardiac osteosarcoma is a very rare type of malignant primary cardiac tumor with limited reported cases. We present a case report of cardiac osteosarcoma
Externí odkaz:
https://doaj.org/article/60b20e4cd0db4f7da8d107a8d8b027d9
Autor:
Jaewon Oh, Chan Joo Lee, Jin Joo Park, Sang Eun Lee, Min‐Seok Kim, Hyun‐Jai Cho, Jin‐Oh Choi, Hae‐Young Lee, Kyung‐Kuk Hwang, Kye Hun Kim, Byung‐Su Yoo, Dong‐Ju Choi, Sang Hong Baek, Eun‐Seok Jeon, Jae‐Joong Kim, Myeong‐Chan Cho, Shung Chull Chae, Byung‐Hee Oh, Seok‐Min Kang
Publikováno v:
ESC Heart Failure, Vol 9, Iss 2, Pp 1492-1495 (2022)
Abstract Aims In 2021, vericiguat was approved by the US Food and Drug Administration (FDA) and the European Commission (EC) for reducing cardiovascular mortality and heart failure (HF) hospitalizations in patients with HF with reduced ejection fract
Externí odkaz:
https://doaj.org/article/80f44211e61549c79cc679b3bafcdeaf
Autor:
Keun-Ho Park, Myung Ho Jeong, Hyun Kuk Kim, Young-Jae Ki, Sung Soo Kim, Youngkeun Ahn, Hyun Yi Kook, Hyo-Soo Kim, Hyeon Cheol Gwon, Ki Bae Seung, Seung Woon Rha, Shung Chull Chae, Chong Jin Kim, Kwang Soo Cha, Jong Seon Park, Jung Han Yoon, Jei Keon Chae, Seung Jae Joo, Dong-Joo Choi, Seung Ho Hur, In Whan Seong, Myeong Chan Cho, Doo Il Kim, Seok Kyu Oh, Tae Hoon Ahn, Jin Yong Hwang, on behalf of the KAMIR-NIH registry investigators
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 2, Pp 350-365 (2022)
Background/Aims While switching strategies of P2Y12 receptor inhibitors (RIs) have sometimes been used in acute myocardial infarction (AMI) patients, the current status of in-hospital P2Y12RI switching remains unknown. Methods Overall, 8,476 AMI pati
Externí odkaz:
https://doaj.org/article/70dfa9205f3c4fd4a2f28f0031ae0d29
Autor:
Sangshin Park, Woong Gil Choia, Dae-Hwan Bae, Min Kim, Ju-Hee Lee, Sangmin Kim, Jang-Whan Bae, Dong-Woon Kim, Myeong-Chan Cho, Chong-Jin Kim, Shung-Chull Chae, Myung-Ho Jeong, Kyung-Kuk Hwang
Publikováno v:
Coronary Artery Disease; Sep2024, Vol. 35 Issue 6, p465-470, 6p
Autor:
Jung Ae Hong, Sang Eun Lee, Seon‐Ok Kim, Min‐Seok Kim, Hae‐Young Lee, Hyun‐Jai Cho, Jin Oh. Choi, Eun‐Seok Jeon, Kyung‐Kuk Hwang, Shung Chull Chae, Sang Hong Baek, Seok‐Min Kang, Dong‐Ju Choi, Byung‐Su Yoo, Kye Hun Kim, Myeong‐Chan Cho, Byung‐Hee Oh, Jae‐Joong Kim
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 283-292 (2022)
Abstract Aims A waiting period of more than 3 months is recommended for patients before undergoing cardiac resynchronization therapy (CRT). However, due to an anticipated high mortality rate, early implementation of CRT might be beneficial for some p
Externí odkaz:
https://doaj.org/article/12f7835dcef24d1f994b727f0a67f5ac